Hemoglobin <scp>A</scp>1c and diagnosis of diabetes
2018 · Journal of Diabetes · 56 citations
https://doi.org/10.1111/1753-0407.12640
S
Shanshan Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
229
Papers
3.8K
Citations
36
h-index
108
i10-index
Shanshan Liu is an academic researcher from Qingdao University. The author has contributed to research in topics: Cancer-related gene regulation & Wnt/β-catenin signaling in development and cancer & Mesenchymal stem cell research. The author has an h-index of 36, co-authored 195 publications.
ORCID: 0009-0007-0775-5616Papers by this author
worksCost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States
2017 · Journal of Managed Care & Specialty Pharmacy · 48 citations
https://doi.org/10.18553/jmcp.2018.24.1.29
Individual heterogeneity screened umbilical cord-derived mesenchymal stromal cells with high Treg promotion demonstrate improved recovery of mouse liver fibrosis
2021 · Stem Cell Research & Therapy · 42 citations
https://doi.org/10.1186/s13287-021-02430-6
FAT4 overexpression promotes antitumor immunity by regulating the β-catenin/STT3/PD-L1 axis in cervical cancer
2023 · Journal of Experimental & Clinical Cancer Research · 40 citations
https://doi.org/10.1186/s13046-023-02758-2
As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma
2021 · International Journal of Biological Sciences · 34 citations
https://doi.org/10.7150/ijbs.66841
Urinary albumin-to-creatinine ratio levels are associated with subclinical atherosclerosis and predict CVD events and all-cause deaths: a prospective analysis
2021 · BMJ Open · 27 citations
https://doi.org/10.1136/bmjopen-2020-040890
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat